Funded Tech Companies
Augustine Therapeutics
Headquartered in Leuven, Augustine Therapeutics has funding from Eli Lilly and Company, V-Bio Ventures and Asabys Partners.
Company Overview
Company Name
Augustine Therapeutics
Company Status
Private & Independent
Industry
Life Sciences
Funding Rounds
Total Funding
Contact Information
Mailing Address
Gaston Geenslaan 1
Leuven, 3001
Belgium
Leuven, 3001
Belgium
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Augustine Therapeutics was founded in 2019 as a spin-off of VIB and KU Leuven. Based on the groundbreaking neurological research of Prof. Ludo Van Den Bosch, this early drug discovery company is building a portfolio of first-in-class therapies for rare neuromuscular neurodegenerative diseases. Augustine Therapeutics' approach is based on new insights into the neuroprotective potential of small-molecule HDAC6 inhibitors.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/26/2024
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Gerhard Koenig
Chief Executive Officer
Sylvain Celanire
Chief Financial Officer
Christophe Van Vaeck
Vice President
Frederik Rombouts
Company Investors
- Eli Lilly and Company
- V-Bio Ventures
- Asabys Partners
- AdBio Partners
- PMV
- Gemma Frisius Fund
- VIB
Browse more funded tech companies:
Augusta University | Aulos Bioscience
Share this article
About Our VC Funding Database
Our data comes from VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs